3-hydroxybutyric acid has been researched along with Angiogenesis, Pathologic in 3 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Min, Z | 1 |
Shichang, Z | 1 |
Chen, X | 1 |
Yufang, Z | 1 |
Changqing, Z | 1 |
Lin, BQ | 1 |
Zeng, ZY | 1 |
Yang, SS | 1 |
Zhuang, CW | 1 |
Otto, C | 1 |
Kaemmerer, U | 1 |
Illert, B | 1 |
Muehling, B | 1 |
Pfetzer, N | 1 |
Wittig, R | 1 |
Voelker, HU | 1 |
Thiede, A | 1 |
Coy, JF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma[NCT05119010] | 60 participants (Anticipated) | Interventional | 2023-03-24 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 other studies available for 3-hydroxybutyric acid and Angiogenesis, Pathologic
Article | Year |
---|---|
3D-printed dimethyloxallyl glycine delivery scaffolds to improve angiogenesis and osteogenesis.
Topics: 3-Hydroxybutyric Acid; Angiogenesis Inducing Agents; Biocompatible Materials; Bone and Bones; Bone M | 2015 |
Dietary restriction suppresses tumor growth, reduces angiogenesis, and improves tumor microenvironment in human non-small-cell lung cancer xenografts.
Topics: 3-Hydroxybutyric Acid; Actins; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferatio | 2013 |
Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides.
Topics: 3-Hydroxybutyric Acid; Adenocarcinoma; Animals; Biomarkers, Tumor; Cell Line, Tumor; Diet, Carbohydr | 2008 |